Overview
Fibromyalgia is a chronic disorder defined by widespread musculoskeletal pain that is often accompanied by profound fatigue, unrefreshing sleep, cognitive difficulty sometimes called "fibro fog," and heightened sensitivity to pressure, temperature, light, and sound. It affects an estimated few percent of adults, is diagnosed far more often in women, and frequently emerges in mid-adulthood, though it can begin at any age. Rather than arising from inflammation or injury in the joints or muscles themselves, it is increasingly understood as a condition of altered pain processing within the nervous system. Because it sits at the intersection of the nervous, endocrine, and immune systems and is closely tied to sleep, stress physiology, and mood, fibromyalgia is a condition where a full-body optimization lens can add useful context alongside a person's own rheumatology or primary care.
The Underlying Biology
Fibromyalgia is characterized by central sensitization, a state in which the central nervous system amplifies pain signaling so that normal or mildly noxious input is experienced as painful. Research describes enhanced excitability in the dorsal horn and brain, reduced descending inhibition through serotonergic and noradrenergic pathways, and elevated excitatory neurotransmitters such as glutamate and substance P in the cerebrospinal fluid. Neuroimaging studies report altered activity and connectivity in pain-processing regions including the insula, anterior cingulate, and thalamus. Autonomic imbalance, often with heightened sympathetic tone and blunted parasympathetic recovery, is frequently observed, alongside dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and the stress-response system. Sleep architecture is commonly disrupted, particularly non-restorative slow-wave sleep, which appears to further lower pain thresholds. A subset of patients shows small-fiber neuropathy on skin biopsy, and low-grade neuroinflammation, glial activation, and mitochondrial and oxidative-stress findings are actively studied. Standard inflammatory and imaging tests are typically normal, so fibromyalgia is framed less as tissue damage and more as a disorder of nervous-system pain modulation shaped by sleep, stress, and neuroendocrine balance.
What the Research Explores
- Explores the role of central sensitization and altered descending pain inhibition in widespread pain sensitivity
- Investigates whether sleep quality, particularly restorative slow-wave sleep, is associated with pain thresholds and fatigue
- Examines how autonomic balance and nervous-system tone relate to symptom patterns and stress reactivity
- Studies the relationship between HPA-axis regulation, cortisol rhythm, and the overall stress-response system
- Considers how graded movement, gentle exercise, and body-composition factors relate to function and comfort
- Investigates emerging findings on small-fiber involvement, glial activation, and neuroinflammation in pain processing
Who May Find This Relevant
- People with fibromyalgia exploring whole-person optimization alongside their rheumatology or primary care
- Those investigating how sleep, stress, and nervous-system tone relate to widespread pain and fatigue
- Individuals tracking symptoms or related labs who want broader, science-forward context
- Caregivers and partners seeking a clear understanding of fibromyalgia as a pain-processing condition
Important Considerations
This page is educational only and is not intended to diagnose, treat, cure, or prevent fibromyalgia or any disease. Fibromyalgia is a medical condition that must be evaluated and managed with your own physician or rheumatology team, and whether and how any optimization support fits alongside that care is decided one-on-one with Dr. Rob, based on your history, labs, and goals. Individual situations and results vary widely, and these statements have not been evaluated by the FDA.
